This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Esreboxetine

Pfizer Inc.

Drug Names(s): S,S-Reboxetine SS-RBX, PNU-165442G

Description: S,S-Reboxetine is the enantiomer (one of two mirror-image molecules) of Reboxetine. Reboxetine is a selective noradrenaline reuptake inhibitor, approved in Europe for the treatment of depression.


Esreboxetine News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug